Xcelerate Acquires Controlling Interest in AfiyaSasa Africa

Xcelerate, Inc. (OTC pink sheets: “XCRT”) today announced it has signed a Membership Interest Purchase Agreement to acquire a 51% interest in AfiyaSasa Africa, LLC, (“ASA”) a start-up medical technology and virtual health company that the Company believes is uniquely positioned to help patients in developing countries meet their medical needs by extending the reach of physicians through the technology.

This technology is centered on software that uses and incorporates artificial intelligence (“AI”) and Augmented Reality (“AR”) developed by AdviNOW. The application is designed to connect people in remote areas where there is limited medical infrastructure and/or limited medical professionals. ASA was recently founded by Dr. Dilan Ellegala and Doyle Word.

“This project, among others, has been at the forefront of our planning ever since Dilan Ellegala joined our Advisory Board in 2021. ASA is uniquely positioned to help the people of Africa meet their medical needs by extending the reach of physicians to their patient’s mobile devices through a patented breakthrough technology.” said Michael O’Shea, Xcelerate’s CEO.

The ASA system is accessed by patients on their cell phones, tablets, or computers, and allows licensed physicians and other medical personnel to conduct initial check-in, triage, and determine the most appropriate care path, virtually. The system is equipped with facial recognition and storage capability to ascertain if the patient is a return patient. Additionally, through a set of questions and answers that are dynamically integrated with the systems proprietary AI component, measurements are taken with medical devices connected to a cell phone, tablet, or computer (e.g. stethoscope, thermometer, pulse oximeter etc.), bringing the telemedicine virtual appointment to the next level.  The AI assists with Q&A and with the AR to arrive at diagnostic possibilities, testing and treatment options and next steps for the patient.

Dr. Ellegala, Co-Founder of ASA, has spent much of his professional life laying the foundation for transformational medical advances in Africa. His training of healthcare workers in remote Tanzania to perform brain and spine surgery and his pioneering work in global medical education is documented in Pulitzer-nominated journalist Tony Barthelme’s book, “A Surgeon in the Village: An American Doctor Teaches Brain Surgery in Africa.” NBC’s Tom Brokaw described the work as “A lyrical, inspirational, altogether rewarding account of first-and third-world surgeons working together to perform neurosurgery miracles in the heart of Africa. “ASA is now poised to take Dr. Ellegala’s foundational work to the highest level by dramatically improving the health care delivery system for hundreds of millions of Africans and we’re excited to be a partner in the project. Xcelerate remains focused on joining early-stage medical technology companies and acquiring and applying patented technology to clinical care world-wide,” said O’Shea.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Kleiner Device Labs will attend the meeting and looks forward to demonstrating the new KG®2 Surge® flow-thru interbody system to surgeons
“Medtronic is continuing our efforts to stop Axonics from profiting off of their unauthorized use of our innovations and intellectual property," said Mira Sahney, president of the pelvic health business in the neuroscience portfolio at Medtronic. "The pattern is clear: Axonics uses Medtronic technologies to improperly compete in the market. It is time for Axonics to be held accountable for these unlawful acts."
The addition of Frank J Veith, MD to the Board underscores ViTAA's commitment to excellence and innovation in the development of medical technologies. His vast experience and achievements will provide critical insights and direction as ViTAA continues to pursue its goal of revolutionizing patient care through cutting-edge solutions.
Ultralife Corporation will join forces with cart manufacturer Karta to launch a complete medical cart and power solution on booth 1237 (Hall A) at HIMSS, from March 12-14, 2024 at the Orange County Convention Center in Orlando, Florida.
“It’s exciting to be one of the first two hospitals in Europe to use Stryker’s Mixed Reality Guidance System,” said Professor Berhouet. “I am also pleased to be leading a pilot study to investigate the safety and effectiveness of this new technology, alongside three other centres in France.”

By using this website you agree to accept Medical Device News Magazine Privacy Policy